- Home
- HCC vs CERT Comparison
HCC vs CERT Comparison
Compare HCC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCC
- CERT
- Stock Information
- Founded
- HCC 2015
- CERT 2008
- Country
- HCC United States
- CERT United States
- Employees
- HCC N/A
- CERT N/A
- Industry
- HCC Coal Mining
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- HCC Energy
- CERT Technology
- Exchange
- HCC Nasdaq
- CERT Nasdaq
- Market Cap
- HCC 2.5B
- CERT 2.3B
- IPO Year
- HCC 2017
- CERT 2020
- Fundamental
- Price
- HCC $46.07
- CERT $11.23
- Analyst Decision
- HCC Strong Buy
- CERT Buy
- Analyst Count
- HCC 5
- CERT 6
- Target Price
- HCC $70.25
- CERT $15.60
- AVG Volume (30 Days)
- HCC 871.0K
- CERT 1.7M
- Earning Date
- HCC 04-30-2025
- CERT 05-05-2025
- Dividend Yield
- HCC 0.70%
- CERT N/A
- EPS Growth
- HCC N/A
- CERT N/A
- EPS
- HCC 2.01
- CERT N/A
- Revenue
- HCC $1,319,451,000.00
- CERT $394,498,000.00
- Revenue This Year
- HCC N/A
- CERT $11.47
- Revenue Next Year
- HCC $31.98
- CERT $9.03
- P/E Ratio
- HCC $22.57
- CERT N/A
- Revenue Growth
- HCC N/A
- CERT 9.37
- 52 Week Low
- HCC $38.00
- CERT $8.64
- 52 Week High
- HCC $75.53
- CERT $17.76
- Technical
- Relative Strength Index (RSI)
- HCC 47.06
- CERT 40.34
- Support Level
- HCC $44.81
- CERT $11.15
- Resistance Level
- HCC $48.68
- CERT $11.75
- Average True Range (ATR)
- HCC 1.75
- CERT 0.39
- MACD
- HCC -0.13
- CERT -0.06
- Stochastic Oscillator
- HCC 33.11
- CERT 17.83
About HCC Warrior Met Coal Inc.
Warrior Met Coal Inc is a U.S based company. It produces and exports of met coal that operates underground mines in Alabama. The company sells to steels manufacturers in Europe, Asia, and South America. Its mining operations consist of two underground met coal mines in Southern Appalachia's coal seam and other surface met and thermal coal mines. The Company generates ancillary revenues from the sale of natural gas extracted as a byproduct from the underground coal mines and royalty revenues from leased properties.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.